Error message

The page you requested does not exist. For your convenience, a search was performed using the query research cambridge cancer trials centre cctc early phase clinical trial team epctt.

Search results

  1. Dr Ali Amin Al Olama

    My research has focused on discovery of genetic risk factors of prostate cancer ...

  2. Dr Ashwin Seshia

    One of the research thrusts in my group is the development of microelectromechanical and microfluidics based platforms for early diagnosis. We also research microfabricated biophysical tools to characterise biological systems ...

  3. Professor Antonis Antoniou

    My main research interest is the development and application of statistical modelling ... tools which are used in clinical practice. I have a research group of 10 which focuses on two broad areas: - the development and ...

  4. Dr Adrien Hallou

    ... PhD in Biophysics at the University of Cambridge. I am now a Research Fellow at Darwin College and a Herchel Smith Research Fellow in the group of Professor Benjamin Simons, where my work ...

  5. Dr Adrian Ionescu

    I currently work as a post-doctoral research associate at the Cavendish Laboratory, Department of Physics, ... of contemporary experimental condensed matter physics research including spintronics, surface science, magnetism at the nanoscale and ... strong track record with international recognition in these research areas, with 50 publications and two books to date. With some of these ...

  6. Dr Aisling Redmond

    ... field at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), partially ... Scientific Associate in Dr Duncan Odom’s lab at the Cancer Research UK Cambridge Institute, analysing non-coding regions of the genome. ...

  7. Dr Alexandre Kabla

    My main research activities focus on the mechanical properties of soft disordered ...

  8. Professor Anna Korhonen

    I conduct research in computer science - in natural language processing and text mining. I have research projects which focus on biomedical text processing and mining, e.g. ... develops text mining technology for the needs of cancer research. ...

  9. Mr Aman Coonar

    Clinical research in thoracic cancer with emphasis on surgery. Local PI for PULMICC ...

  10. Mr Amit Roshan

    ... with a clinical interest in early stage melanoma. My research focus is currently exploring the utility of circulating tumour DNA ...

  11. Dr Andreas Bender

    ... the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges from the analysis of chemical screening data ...

  12. Dr Andrew Gee

    ... and Graham Treece, I lead the Medical Imaging Group at Cambridge University's Engineering Department. Of particular relevance to ...

  13. Mr Angelos Kolias

    ... Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University, ...

  14. Miss Annalisa Occhipinti

    ... and I am doing a PhD in bioinformatics at the University if Cambridge. I am currently working on gene network interactions and cancer data ...

  15. Dr Antony Rix

    ... Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help ...

  16. Professor Tony Green

    ... Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He ... and in 2016 was appointed Director of the Wellcome-MRC Cambridge Stem Cell Institute. In work which has spanned basic, translational ...

  17. Dr Alex Samoshkin

    ... been a Translational Technology Manager in the University of Cambridge since 2017. My primary role is to connect researchers in ...

  18. Dr Alejandra Bruna

    ... aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in ... of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the molecular heterogeneity present in primary ...

  19. Dr Catherine Lindon

    ... to coordinated cell division, and have well documented cancer-promoting activities. Ongoing projects in the lab explore how ... in time and space, and how their activity contributes to cancer. We have recently described a 'ubiquitome' of cellular components ...

  20. Dr Alison Dunning

    Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput ... (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response. In this we collaborate closely ... consortia for breast, ovarian, endometrial and prostate cancer association studies: BCAC http://bcac.ccge.medschl.cam.ac.uk, CIMBA ...

  21. Dr Ashray Gunjur

    ... broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David ... between gut microbiota and outcomes in patients with rare cancer types. ...

  22. Dr Ahsan MEMON

    ... this holographic system was deployed to the study of cancer and stem cell shape regulation and the role of effective membrane ...

  23. Professor Alan Warren

    ... how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome, containing ... it is also important for oncogenesis: a novel class of human cancer predisposition disorder has recently emerged that is caused by mutations ...

  24. Dr Alasdair Russell

    ... we use these novel models in a range of pre-clinical trials to advance our understanding of disease. ...

  25. Dr Amos Burke

    ... role he is responsible for the delivery of clinical cancer trials for Children and Young People in England. ...

  26. Dr Basma Greef

    ... develop new treatments. My other interests include clinical trials and the effective management of toxicities related to widely used ...

  27. Dr Brent O'Carrigan

    - Phase 2/3 clinical trials in renal cancer and melanoma ...

  28. Dr Bristi Basu

    ... findings on lead candidate agents into early phase clinical trials of novel therapeutic drugs as chief investigator, principal investigator ... and industry-sponsored Phase I, II and III clinical trials, including first-in-human and first-in-class studies. My tumour ...

  29. Professor Charlotte Coles

    ... of recurrence. She is Chief Investigator of 4 clinical trials with linked translational research: 1. IMPORT LOW : phase III ...

  30. Ms Ceilidh Welsh

    ... from nearly 3000 patients recruited across radiotherapy trials in Breast Cancer, Prostate Cancer and Head & Neck Cancer. ...

  31. Dr Danish Mazhar

    ... He is the Principal Investigator of numerous clinical trials in Prostate, Bladder and Testis Cancers. He is a member of National ...

  32. Dr David Gilligan

    ... tract cancer and is an enthusiastic participator in clinical trials. He has been a member of the NCRI Lung Cancer Studies Group. He is ...

  33. Dr Anna Piskorz

    ... (Canada), NKI (The Netherlands), VU University Medical Centre (The Netherlands), Institute of Cancer Sciences University of Glasgow ...

  34. Professor Anthony Davenport

    ... trace amines). We collaborate with the Wolfson Brain Imaging Centre to use PET to non-invasively image receptors in vivo using novel peptide ...

  35. Mr Asif Jah

    Mr Asif Jah ...

  36. Professor Chris Rodgers

    ... MRI lab. My group is based at the Wolfson Brain Imaging Centre which has a Siemens 7T Terra MRI scanner. Our research focus is on ...

  37. Dr Daniel Hodson

    Pathogenesis of Germinal Centre Derived B Cell Lymphomas. Many of the commonest human lymphomas ... stage of B lymphocyte differentiation termed the Germinal Centre. Normal B lymphocytes form part of our adaptive immune system. B cells ... compete for T cell help before exiting the germinal centre as immunoglobulin secreting plasma cells or memory B cells, whereas less ...

  38. Dr Annalise Katz-Summercorn

    Early detection in oesophageal adenocarcinoma

  39. Dr Andre Neves

    ... am interested in the use of molecular imaging techniques for early cancer diagnosis and for better assessing response to cancer therapy. ...

  40. Professor Bertie Gottgens

    ... Current research focuses on (i) single cell genomics of early blood development, (ii) computer models to chart the transcriptional ...

  41. Mrs Barbara Newcombe

    ... BRCA1&2 mutation tested, male and female 2. SLN technique in early Vulval cancer 3. randomised surgical intervention for early cervix cancer ...

  42. Professor Kevin Brindle

    ... resonance-based molecular imaging techniques to detect the early responses of tumours to therapy, with a view to translating these into ... responses to an anti-vascular drug and for detecting early tumour responses to immunotherapy. An early apoptotic response following ...

  43. Dr Pippa Corrie

    ... I am chief investigator of the national adjuvant melanoma phase 3 trial, collaborating with Mark Middleton, Oxford, who leads associated ...

  44. Professor Tim Eisen

    ... responsible for oncology trials from first in man to Phase II. ...

  45. Professor Fiona Gilbert

    ... rectal and oesophageal cancers. As lead of the early phase section of the PET research network on behalf of the NCRI I have the ...

  46. Dr Hugo Ford

    ... and gastric cancer. I am chief investigator of a national phase 3 trial of gastric cancer chemotherapy and locally am collaborating with ...

  47. Dr Gaia Schiavon

    - Use of ctDNA analysis for early assessment of response / prediction of long term outcome, and to interrogate minimal residual disease ...

  48. Professor James Brenton

    ... critical pathways in resistance has been to develop novel phase II clinical trials with sequential collection and profiling of ovarian ...

  49. Professor Duncan Jodrell

    ... novel therapeutic combinations, including first into man (phase I) and associated studies.  My research goal is to identify successful, ...

  50. Dr Andrew Pierce

    DNA damage and repair, oncology clinical biomarkers ...

  51. Mr David Chalmers

    I lead the Software Team in the IT and Scientific Computing Department at the CRUK Cambridge ...

  52. Dr Dominick McIntyre

    ... in preclinical MRI and image databases, and running a team supporting research in clinical & preclinical MR, BLI/FLI, CT and ...

  53. Dr Elisa Laurenti

    ... to identify the molecular networks at play in human HSC. Our team are particularly interested in defining how the quiescent status of HSC is ...

  54. Ms Fiona Morgan

    ... are a small, highly interactive and international research team whose passion is using new technological innovations to improve our ...

  55. Dr George Follows

    ... in Cambridge, and chair the Haematology Clinical Trials team. I am a committee member of the Cambridge Clinical Cancer Trials ...

  56. Dr James Hadfield

    ... Science Park. I am working with the rest of the TM Labs Team to drive our use of various epigenome analysis methods such as DNA ...

Pages